Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2025-12-25 @ 2:38 AM
NCT ID:
NCT02962934
Eligibility Criteria:
Inclusion Criteria:
Group 1 Non CRRT
* Diagnosis of systemic infection known or suspected to be caused by an organism susceptible to ceftolozane-tazobactam
* Age more than 18 years
* The treating clinician considers Ceftolozane-tazobactam to be an appropriate agent to treat the infection Group 2 CRRT
* Diagnosis of systemic infection known or suspected to be caused by an organism susceptible to ceftolozane-tazobactam
* Age more than18 years
* Prescribed to receive CRRT
* The treating clinician considers Ceftolozane-tazobactam to be an appropriate agent to treat the infection
Exclusion Criteria:
Group 1 Non CRRT
* Renal dysfunction that necessitates the use of renal replacement therapy
* Known or suspected allergy to cephalosporins
* Receipt of any Pipercillin-Tazobactam for the treatment of this current infection.
* Pregnancy Group 2 CRRT
* Known or suspected allergy to cephalosporins
* Pregnancy
* Receipt of any Pipercillin-Tazobactam for the treatment of this current infection
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02962934
Study Brief:
Protocol Section:
NCT02962934